Ask AI
ProCE Banner Activity

A Year in Review: ADCs Targeting HER2 in NSCLC

Slideset

Download these slides for an expert’s perspective on how to integrate HER2-directed antibody–drug conjugates into management of advanced HER2-mutated NSCLC.

Released: January 29, 2024

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.